Interventions for women with endometrioma prior to assisted reproductive technology
Systematic review / meta-analysis
OA: closed
public-domain-us
Abstract
RATIONALE: The link between endometriosis and infertility has been firmly established; however, the mechanism remains controversial. Management of ovarian endometriosis (endometrioma) in the context of assisted reproductive technology (ART) varies greatly both in regard to the intervention chosen or, indeed, the decision to treat at all. Management remains a key clinical decision for patients requiring fertility treatment and guidance from scientific evidence is vital. This is an update of a Cochrane review first published in 2010.
OBJECTIVES: To assess the effects of surgery, medical treatment, combination therapy (both medical and surgical) or no treatment for improving reproductive outcomes among women with endometrioma, prior to undergoing ART cycles.
SEARCH METHODS: We searched the Cochrane Gynaecology and Fertility Group's specialised register, CENTRAL, MEDLINE, Embase and PsycINFO on 7 October 2025. We also searched trial registries, checked reference lists of relevant studies and contacted experts in the field for any additional trials.
ELIGIBILITY CRITERIA: We selected randomised controlled trials (RCTs) that compared any medical and/or surgical intervention with another medical and/or surgical intervention or placebo/no intervention for the treatment of endometrioma prior to ART. The included population was women with endometrioma diagnosed by laparoscopy or pelvic imaging such as ultrasound, computed tomography (CT), or magnetic-resonance imaging (MRI).
OUTCOMES: Our critical outcomes of interest, as presented in the summary of findings tables, were: live birth and adverse events.
RISK OF BIAS: We used the Cochrane RoB 1 tool to assess bias in the included studies.
SYNTHESIS METHODS: Due to significant heterogeneity between the included studies, we synthesised the results into a narrative review. We summarised key findings from individual studies descriptively and we structured them by outcome domain. We used GRADE to assess the certainty of evidence for the critical outcomes.
INCLUDED STUDIES: We included a total of seven parallel-arm RCTs with 646 participants randomised. Two studies (173 participants) evaluated medical interventions and five studies (473 participants) evaluated surgical interventions for endometrioma prior to ART. No studies evaluated combination therapy.
SYNTHESIS OF RESULTS: No clear benefit was found for any treatment over no treatment. We judged all studies to have a high or unclear risk of bias in at least two domains and graded the evidence as very low certainty as a result of this and imprecision due to low study numbers and wide confidence intervals. Below we report the critical outcomes, as presented in the summary of findings tables. Medical intervention: GnRH agonist protocol compared to control for ART The evidence is very uncertain about the effect of a GnRH agonist protocol compared to control on live birth (OR 3.70, 95% CI 1.25 to 10.90; 1 study, 64 participants; very low-certainty evidence). Adverse events were not reported. Surgical intervention (s): Endometrioma aspiration versus no aspiration The evidence is very uncertain about the effect of endometrioma aspiration compared to control on live birth (OR 1.66, 95% CI 0.59 to 4.62; 1 study, 81 participants; very low-certainty evidence). Adverse events were not reported. Endometrioma cystectomy versus no cystectomy The evidence is very uncertain about the effect of endometrioma cystectomy compared to control on live birth (OR 1.97, 95% CI 0.71 to 5.49; 1 study, 73 participants; very low-certainty evidence). Zero adverse events were reported in each study arm (1 study, 73 participants; very low-certainty evidence). Endometrioma transvaginal sclerotherapy versus no sclerotherapy No included study assessed live birth. Adverse events were not reported.
AUTHORS' CONCLUSIONS: This narrative review highlights the uncertainties regarding the management of endometrioma prior to ART. There is no high-certainty evidence that might change the current guidance for management plans to be developed on an individual basis, taking into account previous outcomes, ovarian reserve, and patient's wishes. Further robust, adequately powered studies are required to guide future clinical decision-making which include critical outcomes as per the core outcome set for endometriosis.
FUNDING: This Cochrane review had no dedicated funding.
REGISTRATION: Protocol (2010) https://doi.org/10.1002/14651858.CD008571. Original review (2010) https://doi.org/10.1002/14651858.CD008571.pub2.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (46)
- Aspiration of ovarian endometriomas before intracytoplasmic sperm injection via openalex
- Can Laparoscopic Cystectomy Improve Pregnancy Outcomes in Endometrioma? A Prospective Clinical Trial Study via openalex
- Effect of endometrioma cystectomy on IVF outcome: a prospective randomized study via openalex
- Effect of Prolonged GnRH Agonist Downregulation on ICSI Outcome in Patients With Endometriomas of Less Than 5 cm: A Randomized Controlled Trial via openalex
- Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study via openalex
- Endometriosis and infertility: a committee opinion via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Epidemiology of endometriosis via openalex
- Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members via openalex
- Evidence based management of patients with endometriosis undergoing assisted conception: British fertility society policy and practice recommendations via openalex
- GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles via openalex
- Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors via openalex
- Is Endometriosis More Common and More Severe Than It Was 30 Years Ago? via openalex
- Isolated Ovarian Endometrioma: A History Between Myth and Reality via openalex
- Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis via openalex
- Management of ovarian endometriomas via openalex
- Outcomes of ovarian endometrioma aspiration before ultra-long agonist protocol during ICSI cycles: a multicenter randomized clinical trial via openalex
- Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Progestogens for endometriosis: forward to the past via openalex
- Rapid recurrence of endometrioma after transvaginal ultrasound-guided aspiration via openalex
- Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications via openalex
- The Effect of Surgery on Endometriomas on Fertility (2025 Second Edition): Scientific Impact Paper No 55 via openalex
- The effect of surgical management of endometrioma on the IVF/ICSI outcomes when compared with no treatment? A systematic review and meta-analysis via openalex
- The evidence for the management of endometriosis via openalex
- The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis via openalex
- The Main Theories on the Pathogenesis of Endometriosis via openalex
- The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies via openalex
- US guided aspiration and 95% ethanol sclerotherapy of ovarian endometrioma before IVF/ICSI via openalex
- W3168961113 via openalex
- W4214754424 via openalex
- W4234160457 via openalex
- W2038124725 via openalex
- W4301183088 via openalex
- W4381250920 via openalex
- W4404718485 via openalex
- W3013010875 via openalex
- W2374105683 via openalex
- W2098923148 via openalex
- W2097972396 via openalex
- W2090062842 via openalex
- W2079190330 via openalex
- W2067197970 via openalex
- W2996101359 via openalex
- W2155198413 via openalex
- W3123893780 via openalex
Source provenance
- europepmc
- last seen: 2026-11-19T06:13:19.037553+00:00
- openalex
- last seen: 2026-11-19T06:04:33.792782+00:00
- pubmed
- last seen: 2026-11-19T06:06:24.241706+00:00
- unpaywall
- last seen: 2026-11-19T08:49:44.633026+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine